-
U.K. Prime Minister David Cameron was accused of hypocrisy after he said he held a stake in an offshore fund set up by his late father until six years ago, an admission broadcast on national television following four days of questions over the investment.
April 8 -
The Internal Revenue Service sent out more than $330 billion in refunds to U.S. taxpayers last year. To capture some of this year's cash, and jump on a marketing opportunity, companies are offering freebies and discounts celebrating the end of the annual filing ordeal.
April 8 -
Highlights of some of our favorite tax-related blogs from the past week.
April 7 -
Anton & Chia, LLP and Anton, Bryson & Schindler Chartered Professional Accountants LLP have completed a tiered acquisition of McCormack, Su & Company in the U.S. and Canada in an effort to grow their Asia practice.
April 7 -
Among the issues that are keeping tax executives up at night are anti-inversion rules that dont address the root cause: an anti-competitive U.S. tax system.
April 7 -
According to the Internal Revenue Service, 28 percent of taxpayers wait until the last few weeks of tax season to file their taxes, and that adds more pressure to their tax preparers.
April 7 -
The IRS is requesting nominations for its Information Reporting Program Advisory Committee, a federal advisory committee that advises the service on various tax administration issues.
April 7 -
The Internal Revenue Services extra $290 million in funding this year helped the IRS improve its level of responsiveness to taxpayer phone calls, according to a new report.
April 7 -
European Union proposals to crack down on corporate-tax avoidance are getting stuck in a fight over how to curb aggressive tax strategies through foreign ownership, threatening the possibility of a deal by June.
April 7 -
The White House traded accusations of unpatriotic behavior with the CEO of a major drugmaker after unexpectedly tough new rules from the U.S. Treasury Department on corporate inversions derailed a $160 billion merger between Pfizer Inc. and Allergan Plc.
April 6
